Showing results (31-40 of 193) with videos related to

Sort By:
Pageof 20
Prostate Cancer and Prostatic Diseases|February 21, 2026
Modern day cost analysis demonstrates medical therapy as a highly cost‑effective first‑line treatment for BPH/LUTSAlexis E Te, Ashwin Ramaswamy, Steven A Kaplan
Therapeutic Advances in Urology|April 13, 2012
Optimizing the management of benign prostatic hyperplasiaDean S Elterman, Jack Barkin, Steven A Kaplan
Current Urology Reports|July 20, 2014
Evaluation and management of post-transurethral resection of the prostate lower urinary tract symptomsBilal Chughtai, Vannita Simma-Chiang, Steven A Kaplan
The Journal of Urology|April 25, 2008
Tolterodine extended release attenuates lower urinary tract symptoms in men with benign prostatic hyperplasiaSteven A Kaplan, Konstantin Walmsley, Alexis E Te
The Urologic Clinics of North America|October 17, 2025
Medical Therapy for Benign Prostatic Hyperplasia and Lower Urinary Tract SymptomsAlexis E Te, Ashwin Ramaswamy, Steven A Kaplan
The Journal of Urology|November 11, 2005
Tolterodine extended release attenuates lower urinary tract symptoms in men with benign prostatic hyperplasiaSteven A Kaplan, Konstantin Walmsley, Alexis E Te
Reviews in Urology|February 20, 2020
Long-term Consequences of Medical Therapy for Benign Prostatic HyperplasiaEric M Bortnick, Vannita Simma-Chiang, Steven A Kaplan
Urology|March 4, 2014
Do patient characteristics predict responsiveness to treatment of overactive bladder with antimuscarinic agents?Sender Herschorn, Steven A Kaplan, Franklin Sun, et al.
Pageof 20